204 related articles for article (PubMed ID: 31891633)
1. Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure.
van den Hoogen P; de Jager SCA; Mol EA; Schoneveld AS; Huibers MMH; Vink A; Doevendans PA; Laman JD; Sluijter JPG
PLoS One; 2019; 14(12):e0227283. PubMed ID: 31891633
[TBL] [Abstract][Full Text] [Related]
2. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit
Bolli R; Hare JM; March KL; Pepine CJ; Willerson JT; Perin EC; Yang PC; Henry TD; Traverse JH; Mitrani RD; Khan A; Hernandez-Schulman I; Taylor DA; DiFede DL; Lima JAC; Chugh A; Loughran J; Vojvodic RW; Sayre SL; Bettencourt J; Cohen M; Moyé L; Ebert RF; Simari RD;
Circ Res; 2018 Jun; 122(12):1703-1715. PubMed ID: 29703749
[TBL] [Abstract][Full Text] [Related]
3. A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.
Bolli R; Mitrani RD; Hare JM; Pepine CJ; Perin EC; Willerson JT; Traverse JH; Henry TD; Yang PC; Murphy MP; March KL; Schulman IH; Ikram S; Lee DP; O'Brien C; Lima JA; Ostovaneh MR; Ambale-Venkatesh B; Lewis G; Khan A; Bacallao K; Valasaki K; Longsomboon B; Gee AP; Richman S; Taylor DA; Lai D; Sayre SL; Bettencourt J; Vojvodic RW; Cohen ML; Simpson L; Aguilar D; Loghin C; Moyé L; Ebert RF; Davis BR; Simari RD;
Eur J Heart Fail; 2021 Apr; 23(4):661-674. PubMed ID: 33811444
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles secreted by bone marrow- and adipose tissue-derived mesenchymal stromal cells fail to suppress lymphocyte proliferation.
Gouveia de Andrade AV; Bertolino G; Riewaldt J; Bieback K; Karbanová J; Odendahl M; Bornhäuser M; Schmitz M; Corbeil D; Tonn T
Stem Cells Dev; 2015 Jun; 24(11):1374-6. PubMed ID: 25779336
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.
Doeppner TR; Herz J; Görgens A; Schlechter J; Ludwig AK; Radtke S; de Miroschedji K; Horn PA; Giebel B; Hermann DM
Stem Cells Transl Med; 2015 Oct; 4(10):1131-43. PubMed ID: 26339036
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles.
Gómez-Ferrer M; Villanueva-Badenas E; Sánchez-Sánchez R; Sánchez-López CM; Baquero MC; Sepúlveda P; Dorronsoro A
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810359
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes.
Del Fattore A; Luciano R; Pascucci L; Goffredo BM; Giorda E; Scapaticci M; Fierabracci A; Muraca M
Cell Transplant; 2015; 24(12):2615-27. PubMed ID: 25695896
[TBL] [Abstract][Full Text] [Related]
8. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction.
Barile L; Lionetti V; Cervio E; Matteucci M; Gherghiceanu M; Popescu LM; Torre T; Siclari F; Moccetti T; Vassalli G
Cardiovasc Res; 2014 Sep; 103(4):530-41. PubMed ID: 25016614
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.
Potter DR; Miyazawa BY; Gibb SL; Deng X; Togaratti PP; Croze RH; Srivastava AK; Trivedi A; Matthay M; Holcomb JB; Schreiber MA; Pati S
J Trauma Acute Care Surg; 2018 Feb; 84(2):245-256. PubMed ID: 29251710
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis.
Zheng G; Huang R; Qiu G; Ge M; Wang J; Shu Q; Xu J
Cell Tissue Res; 2018 Oct; 374(1):1-15. PubMed ID: 29955951
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Urine Stem Cell-Derived Extracellular Vesicles Reveals B Cell Stimulating Cargo.
Zidan AA; Al-Hawwas M; Perkins GB; Mourad GM; Stapledon CJM; Bobrovskaya L; Zhou XF; Hurtado PR
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466423
[TBL] [Abstract][Full Text] [Related]
13. The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury.
Ranghino A; Bruno S; Bussolati B; Moggio A; Dimuccio V; Tapparo M; Biancone L; Gontero P; Frea B; Camussi G
Stem Cell Res Ther; 2017 Feb; 8(1):24. PubMed ID: 28173878
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders.
Kahmini FR; Shahgaldi S
Exp Mol Pathol; 2021 Feb; 118():104566. PubMed ID: 33160961
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
Front Immunol; 2018; 9():2538. PubMed ID: 30473695
[TBL] [Abstract][Full Text] [Related]
16. Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction.
Garbayo E; Ruiz-Villalba A; Hernandez SC; Saludas L; Abizanda G; Pelacho B; Roncal C; Sanchez B; Palacios I; Prósper F; Blanco-Prieto MJ
Acta Biomater; 2021 May; 126():394-407. PubMed ID: 33716175
[TBL] [Abstract][Full Text] [Related]
17. Diverse impact of xeno-free conditions on biological and regenerative properties of hUC-MSCs and their extracellular vesicles.
Bobis-Wozowicz S; Kmiotek K; Kania K; Karnas E; Labedz-Maslowska A; Sekula M; Kedracka-Krok S; Kolcz J; Boruczkowski D; Madeja Z; Zuba-Surma EK
J Mol Med (Berl); 2017 Feb; 95(2):205-220. PubMed ID: 27638341
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive properties of cytochalasin B-induced membrane vesicles of mesenchymal stem cells: comparing with extracellular vesicles derived from mesenchymal stem cells.
Gomzikova MO; Aimaletdinov AM; Bondar OV; Starostina IG; Gorshkova NV; Neustroeva OA; Kletukhina SK; Kurbangaleeva SV; Vorobev VV; Garanina EE; Persson JL; Jeyapalan J; Mongan NP; Khaiboullina SF; Rizvanov AA
Sci Rep; 2020 Jul; 10(1):10740. PubMed ID: 32612100
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts.
Lima Correa B; El Harane N; Gomez I; Rachid Hocine H; Vilar J; Desgres M; Bellamy V; Keirththana K; Guillas C; Perotto M; Pidial L; Alayrac P; Tran T; Tan S; Hamada T; Charron D; Brisson A; Renault NK; Al-Daccak R; Menasché P; Silvestre JS
Cardiovasc Res; 2021 Jan; 117(1):292-307. PubMed ID: 32049348
[TBL] [Abstract][Full Text] [Related]
20. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
